These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 12884157
1. Dilemmas in the treatment of invasive Streptococcus pyogenes infections. Stevens DL. Clin Infect Dis; 2003 Aug 01; 37(3):341-3. PubMed ID: 12884157 [No Abstract] [Full Text] [Related]
3. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients. Norrby-Teglund A, Low DE, McGeer A, Kotb M. Adv Exp Med Biol; 1997 Aug 01; 418():563-6. PubMed ID: 9331714 [No Abstract] [Full Text] [Related]
5. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A. Clin Infect Dis; 2004 Mar 15; 38(6):836-42. PubMed ID: 14999628 [Abstract] [Full Text] [Related]
14. T cell activation and cytokine release in streptococcal toxic shock-like syndrome. Nadal D, Lauener RP, Braegger CP, Kaufhold A, Simma B, Lütticken R, Seger RA. J Pediatr; 1993 May 15; 122(5 Pt 1):727-9. PubMed ID: 8496751 [Abstract] [Full Text] [Related]
15. Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock. Llewelyn M. Clin Infect Dis; 2005 Nov 15; 41 Suppl 7():S445-8. PubMed ID: 16237645 [Abstract] [Full Text] [Related]
16. Group A streptococcal infections. An old adversary reemerging with new tricks? Feingold DS, Weinberg AN. Arch Dermatol; 1996 Jan 15; 132(1):67-70. PubMed ID: 8546486 [No Abstract] [Full Text] [Related]